
Jennifer P. Nock
Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR
Biosimilars Law Bulletin ·
PTAB Institutes a Second IPR on Rituxan®-related ’821 Patent
Biosimilars Law Bulletin ·
Immunex Loses Battle Over Institution of Follow-on IPR Petitions
Biosimilars Law Bulletin ·
Supreme Court Oral Argument in <i>Oil States</i>
PTAB Law Blog ·